86 related articles for article (PubMed ID: 31932217)
1. Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
Chan ST; Ruan D; Shaverdian N; Raghavan G; Cao M; Lee P
Clin Lung Cancer; 2020 Mar; 21(2):136-144.e1. PubMed ID: 31932217
[TBL] [Abstract][Full Text] [Related]
2. The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study.
de Ruiter JC; van der Noort V; van Diessen JNA; Smit EF; Damhuis RAM; Hartemink KJ;
Lung Cancer; 2024 May; 191():107792. PubMed ID: 38621343
[TBL] [Abstract][Full Text] [Related]
3. The management of stage I Non-Small cell lung cancer (NSCLC) in Ontario: A Population-Based study of patterns of care and Stereotactic Ablative Body radiotherapy (SABR) utilization from 2010 to 2019.
Ashworth A; Kong W; Owen T; Hanna TP; Brundage M
Radiother Oncol; 2024 May; 194():110153. PubMed ID: 38364940
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer.
Borghetti P; Costantino G; Santoro V; Mataj E; Singh N; Vitali P; Greco D; Volpi G; Sepulcri M; Guida C; Tomasi C; Buglione M; Nardone V
In Vivo; 2024; 38(3):1359-1366. PubMed ID: 38688600
[TBL] [Abstract][Full Text] [Related]
5. A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Tonneau M; Richard C; Routy B; Campeau MP; Vu T; Filion E; Roberge D; Mathieu D; Doucet R; Beliveau-Nadeau D; Bahig H
Radiother Oncol; 2023 Aug; 185():109697. PubMed ID: 37169303
[TBL] [Abstract][Full Text] [Related]
6. An optimal dose-fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early-stage non-small lung cancer.
Zarębska I; Harat M
Thorac Cancer; 2023 Oct; 14(28):2813-2820. PubMed ID: 37691151
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review.
Wang S; Wang X; Zhou Q; Xu Y; Xia W; Xu W; Ma Z; Qiu M; You R; Xu L; Yin R
Thorac Cancer; 2018 Mar; 9(3):337-347. PubMed ID: 29322682
[TBL] [Abstract][Full Text] [Related]
8. Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation.
Yegya-Raman N; Ho Lee S; Friedes C; Wang X; Iocolano M; Kegelman TP; Duan L; Li B; Berlin E; Kim KN; Doucette A; Denduluri S; Levin WP; Cengel KA; Cohen RB; Langer CJ; Kevin Teo BK; Zou W; O'Quinn RP; Deasy JO; Bradley JD; Sun L; Ky B; Xiao Y; Feigenberg SJ
Radiother Oncol; 2024 Jan; 190():110005. PubMed ID: 37972736
[TBL] [Abstract][Full Text] [Related]
9. Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC.
Brooks ED; Verma V; Senan S; De Baere T; Lu S; Brunelli A; Chang JY;
J Thorac Oncol; 2020 Feb; 15(2):176-189. PubMed ID: 31712134
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer.
Kocak Uzel E; Bagci Kilic M; Morcali H; Uzel O
Sci Rep; 2023 Jun; 13(1):10384. PubMed ID: 37369756
[TBL] [Abstract][Full Text] [Related]
11. Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
Lee SH; Geng H; Arnold J; Caruana R; Fan Y; Rosen MA; Apte AP; Deasy JO; Bradley JD; Xiao Y
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1270-1286. PubMed ID: 37343707
[TBL] [Abstract][Full Text] [Related]
12. Baseline shift corrections towards the heart: External validation of the impact on survival in early-stage NSCLC patients.
Juan-Cruz C; Stam B; Rossi M; Belderbos J; Sonke JJ
Radiother Oncol; 2024 Jun; 195():110214. PubMed ID: 38458257
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
Yegya-Raman N; Wang K; Kim S; Reyhan M; Deek MP; Sayan M; Li D; Patel M; Malhotra J; Aisner J; Marks LB; Jabbour SK
J Thorac Oncol; 2018 Oct; 13(10):1508-1518. PubMed ID: 29883836
[TBL] [Abstract][Full Text] [Related]
14. Proton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancer.
Grant JD; Chang JY
Biomed Res Int; 2014; 2014():389048. PubMed ID: 25136582
[TBL] [Abstract][Full Text] [Related]
15. Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study.
Walls GM; O'Connor J; Harbinson M; McCarron EP; Duane F; McCann C; McKavanagh P; Johnston DI; Erekkath J; Giacometti V; Gavin AT; McAleese J; Hounsell AR; Cole AJ; Butterworth KT; McGarry CK; Hanna GG; Jain S
Radiother Oncol; 2023 Sep; 186():109762. PubMed ID: 37348608
[TBL] [Abstract][Full Text] [Related]
16. The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study.
Walls GM; O'Connor J; Harbinson M; Duane F; McCann C; McKavanagh P; Johnston DI; Giacometti V; McAleese J; Hounsell AR; Cole AJ; Butterworth KT; McGarry CK; Hanna GG; Jain S
Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):119-127. PubMed ID: 38042669
[TBL] [Abstract][Full Text] [Related]
17. Discussion to: Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
J Thorac Cardiovasc Surg; 2024 Mar; 167(3):834-835. PubMed ID: 37865894
[No Abstract] [Full Text] [Related]
18. Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy.
Jin Z; Sun X; Zhou C; Yang H; Zhou S
Neoplasia; 2024 Feb; 48():100969. PubMed ID: 38199173
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer?
Chen H; Louie AV
Ann Transl Med; 2015 Jun; 3(9):113. PubMed ID: 26207241
[TBL] [Abstract][Full Text] [Related]
20. Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study.
Olloni A; Brink C; Lorenzen EL; Jeppesen SS; Hofmann L; Kristiansen C; Knap MM; Møller DS; Nygård L; Persson GF; Thing RS; Sand HMB; Diederichsen A; Schytte T
JTO Clin Res Rep; 2024 Apr; 5(4):100663. PubMed ID: 38590728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
